Show
Sort by
-
- Journal Article
- A1
- open access
Glycosylation analysis of urinary peptidome highlights IGF2 glycopeptides in association with CKD
-
The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease
-
- Journal Article
- A1
- open access
Data sharing under the General Data Protection Regulation : time to harmonize law and research ethics?
-
Value of urinary proteome-based classifier associated with chronic kidney disease and its progression in the prognosis of a patient-relevant endpoint, mortality
-
A urinary proteome-based classifier for the early detection of decline in glomerular filtration
-
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis
-
- Journal Article
- A1
- open access
Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker
-
Urinary proteomics analysis reveals multiple features associated with chronic kidney disease progression
-
Possible role of microRNAs in CKD progression
-
Proteomic biomarkers in kidney disease: issues in development and implementation
-
Urinary proteomics to decipher molecular pathophysiology of CKD progression
-
New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis
-
High-resolution plasma proteome analysis identifies new changes in molecular mechanisms involved in chronic kidney disease
-
Diagnosis and prediction of CKD progression by assessment of urinary peptides
-
Implementation of proteomic biomarkers: making it work